Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients

Table 4 Comparison between recovered and non-recovered patients regarding age, sex, pre-transplant laboratory investigations and pre-transplant Child and model for end-stage liver disease scores

Variable	Recovered (n = 5) (median ± IQR)	Non-recovered (n = 11) (median ± IQR)	Z1	P value
INR	1.5 ± 0.5	1.7 ± 0.5	2.231	0.027
ALT	25 ± 51	38 ± 36	0.397	0.743
AST	49 ± 45.5	53 ± 39	0.283	0.827
Total bilirubin	1.4 ± 1	3.1 ± 2.9	2.437	0.013
Albumin	2.3 ± 1	2.3 ± 0.5	1.208	0.267
Creatinine	0.7 ± 0.5	0.9 ± 0.4	0.517	0.661
BUN	11 ± 11.5	12 ± 5	0.514	0.636
Sodium	139 ± 12.5	132 ± 7	0.910	0.377
Potassium	4 ± 1.2	3.6 ± 0.8	1.310	0.221
Calcium	8.9 ± 0.7	8.3 ± 1.3	0.746	0.482
Phosphorus	2.7 ± 0.8	3.2 ± 1.3	1.204	0.259
Magnesium	2.3 ± 0.6	2 ± 0.6	0.969	0.355
Child-Pugh score	9 ± 1.5	11 ± 1	2.140	0.038
MELD score	13 ± 3.5	17 ± 5	2.557	0.009
Age (mean ± SD)	56.6 ± 1.7	51.2 ± 6.1	1.9112	0.077
Sex
Male (n, %)	4 (80)	9 (81.8)	0.0073	1.000
Female (n, %)	1 (20)	2 (18.2)

¹Mann Whitney U test;

²Independent samples t-test;

³χ², Fisher’s exact test. INR: International normalized ratio; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BUN: Blood urea nitrogen; MELD: Model for end-stage liver disease; IQR: Inter-quartile range; SD: Standard deviation.